LCD L36117: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease — CGS
Policy LCD-L36117 · Hematology
New genetic testing LCD affects billing for myeloproliferative disease.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code D45.
Signal breakdown
9 shown · 9 total in platform
Critical
0%
High
33%
Routine
67%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L36117 · Hematology
New genetic testing LCD affects billing for myeloproliferative disease.
Policy LCD-L36044 · Hematology
New guidelines impact billing for genetic tests in myeloproliferative disease.
Policy LCD-L36815 · Hematology
New LCD impacts billing for myeloproliferative disease testing.
Policy LCD-L39927 · Hematology
New LCD for myeloproliferative neoplasm testing impacts billing.
Policy LCD-L36094 · Clinical Laboratory
New LCD for Flow Cytometry affects lab billing practices.
Policy LCD-L34215 · Clinical Laboratory
Noridian's Flow Cytometry LCD impacts billing guidelines.
Policy LCD-L39923 · Hematology
Changes in billing for myeloproliferative neoplasms testing ahead.
Policy LCD-L40000 · Hematology
New LCD impacts billing for myeloproliferative neoplasms testing.
Policy LCD-L37622 · Clinical Laboratory
Understanding MDS FISH LCD billing is crucial for labs.
Audit documentation
The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.